Dekker J W, Easteal S, Jakobsen I B, Gao X, Stewart G J, Buhler M M, Hawkins B R, Higgins D A, Yu Y L, Serjeantson S W
Human Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra.
Tissue Antigens. 1993 Jan;41(1):31-6. doi: 10.1111/j.1399-0039.1993.tb01974.x.
Multiple sclerosis (MS) is a demyelinating disease associated with the HLA-DR2-related haplotype DRB11501, DQB10602 in Caucasoids and with DQB10602 in DR2-positive Cantonese. However, many MS patients do not have the high-risk HLA-D determinants and alternative genes may contribute to the pathogenesis of MS. One candidate gene is HLA-DPB1. Our reanalysis of five earlier reports of HLA-DPB1 antigen distributions in Caucasoid MS patients shows a consistent and highly significant increase (p = 1.5 x 10(-5)) in frequency of HLA-DPw3 in the combined data set. This study tests whether HLA-DPw3 (DPB10301) is also increased in frequency in Australian and Cantonese MS patients and whether any distortion in DPB1 allelic distributions can be attributed to linkage disequilibrium with DQB10602. PCR-RFLPs were used to determine distributions of 20 HLA-DPB1 alleles in 41 Australian MS patients and 67 controls of known DQB10602 status and in 11 Cantonese MS patients and 33 controls positive for HLA-DR2. HLA-DP distributions in Australian MS patients and controls positive for DQB10602 did not differ, but in those MS patients lacking DQB10602, the DPB10301 antigen (phenotype) frequency was significantly (p = 0.006) increased (50.0%) when compared with DQB10602-negative controls (9.1%). DPB10301 was associated (p = 0.003) with DQB10402 (DR8) in Caucasoid MS patients.(ABSTRACT TRUNCATED AT 250 WORDS)
多发性硬化症(MS)是一种脱髓鞘疾病,在白种人中与HLA - DR2相关单倍型DRB11501、DQB10602相关,在DR2阳性的广东人中与DQB10602相关。然而,许多MS患者没有高危HLA - D决定簇,其他基因可能参与了MS的发病机制。一个候选基因是HLA - DPB1。我们对之前五篇关于白种人MS患者中HLA - DPB1抗原分布报告的重新分析显示,在合并数据集中HLA - DPw3的频率一致且显著增加(p = 1.5×10⁻⁵)。本研究检测HLA - DPw3(DPB10301)在澳大利亚和广东MS患者中的频率是否也增加,以及DPB1等位基因分布的任何偏差是否可归因于与DQB10602的连锁不平衡。采用聚合酶链反应 - 限制性片段长度多态性(PCR - RFLPs)方法确定41例澳大利亚MS患者和67例已知DQB10602状态的对照以及11例广东MS患者和33例HLA - DR2阳性对照中20种HLA - DPB1等位基因的分布。澳大利亚MS患者和DQB10602阳性对照中的HLA - DP分布无差异,但在那些缺乏DQB10602的MS患者中,与DQB10602阴性对照(9.1%)相比,DPB10301抗原(表型)频率显著增加(p = 0.006)(50.0%)。在白种人MS患者中,DPB10301与DQB10402(DR8)相关(p = 0.003)。(摘要截于250字)